Insider Trading Screener
| Ticker | Issuer Name | Owner Name | Relationship | Transaction Date | Transaction | Shares | Price/Share | Total Value | Shares Owned |
|---|---|---|---|---|---|---|---|---|---|
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 144 | 349.53 | 50,332.32 | 131,273 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 1,803 | 351.95 | 634,565.85 | 129,470 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 13,619 | 352.46 | 4,800,152.74 | 115,851 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 12,796 | 353.48 | 4,523,130.08 | 103,055 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 2,557 | 354.50 | 906,456.50 | 100,498 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 3,912 | 355.60 | 1,391,107.20 | 96,586 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 4,611 | 356.55 | 1,644,052.05 | 91,975 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 3,133 | 357.24 | 1,119,232.92 | 88,842 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 863 | 358.55 | 309,428.65 | 87,979 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 699 | 359.62 | 251,374.38 | 87,280 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 498 | 360.25 | 179,404.50 | 86,782 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 1,227 | 361.27 | 443,278.29 | 85,555 |
| RL | RALPH LAUREN CORP | Louvet Patrice | Director Officer | 2026-02-10 | S - D | 3 | 362.10 | 1,086.30 | 85,552 |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | 2026-02-10 | S - D | 438 | 23.12 | 10,126.56 | 81,721 | |
| LYEL | Lyell Immunopharma, Inc. | Seely Lynn | 2026-02-10 | A - A | 155,000 | 0.00 | 0.00 | 155,000 | |
| LYEL | Lyell Immunopharma, Inc. | Meltz Mark A | 2026-02-10 | A - A | 50,000 | 0.00 | 0.00 | 50,000 | |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | 2026-02-10 | S - D | 109 | 23.12 | 2,520.08 | 19,031 | |
| LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | 2026-02-10 | A - A | 65,000 | 0.00 | 0.00 | 65,000 | |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | 2026-02-10 | S - D | 147 | 23.12 | 3,398.64 | 18,609 | |
| LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | 2026-02-10 | A - A | 50,000 | 0.00 | 0.00 | 50,000 | |
| LYEL | Lyell Immunopharma, Inc. | Shook David | 2026-02-10 | A - A | 50,000 | 0.00 | 0.00 | 50,000 | |
| LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | 2026-02-10 | A - A | 8,750 | 0.00 | 0.00 | 15,891 | |
| LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | 2026-02-10 | S - D | 254 | 23.12 | 5,872.48 | 15,637 | |
| MHO | M/I HOMES, INC. | SCHOTTENSTEIN ROBERT H | Director Officer | 2026-02-10 | M - A | 20,000 | 42.23 | 844,600.00 | 333,874 |
| MHO | M/I HOMES, INC. | SCHOTTENSTEIN ROBERT H | Director Officer | 2026-02-10 | S - D | 20,000 | 144.47 | 2,889,342.00 | 313,874 |